NF Trinity Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $6.54M | Buy |
137,000
+44,000
| +47% | +$2.1M | 1.04% | 25 |
|
|
2018
Q4 | $4.83M | Hold |
93,000
| – | – | 0.79% | 30 |
|
|
2018
Q3 | $5.77M | Hold |
93,000
| – | – | 0.76% | 35 |
|
|
2018
Q2 | $5.15M | Hold |
93,000
| – | – | 0.7% | 35 |
|
|
2018
Q1 | $5.88M | Sell |
93,000
-93,000
| -50% | -$5.88M | 0.81% | 32 |
|
|
2017
Q4 | $11.4M | Hold |
186,000
| – | – | 1.48% | 15 |
|
|
2017
Q3 | $11.9M | Hold |
186,000
| – | – | 1.69% | 15 |
|
|
2017
Q2 | $10.4M | Hold |
186,000
| – | – | 1.47% | 16 |
|
|
2017
Q1 | $10.1M | Hold |
186,000
| – | – | 1.37% | 17 |
|
|
2016
Q4 | $10.9M | Sell |
186,000
-100,000
| -35% | -$5.84M | 1.53% | 17 |
|
|
2016
Q3 | $15.4M | Hold |
286,000
| – | – | 1.72% | 16 |
|
|
2016
Q2 | $21M | Sell |
286,000
-100,000
| -26% | -$7.35M | 2.3% | 15 |
|
|
2016
Q1 | $24.7M | Buy |
386,000
+64,000
| +20% | +$4.09M | 2.99% | 10 |
|
|
2015
Q4 | $22.2M | Buy |
+322,000
| New | +$22.2M | 2.52% | 10 |
|